Evidence map›Paper›PMID 20858759›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2010

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.

Meng Chen, Michelle A T Hildebrandt, Jessica Clague, Ashish M Kamat, Antoni Picornell, Joshua Chang, Xiaofan Zhang, Julie Izzo, Hushan Yang, Jie Lin and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Meng ChenDepartment of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Michelle A T Hildebrandt
Jessica Clague
Ashish M Kamat
Antoni Picornell
Joshua Chang
Xiaofan Zhang
Julie Izzo
Hushan Yang
Jie Lin
Jian Gu
Stephen Chanock
Manolis Kogevinas
Nathaniel Rothman
Debra T Silverman
Montserrat Garcia-Closas
H Barton Grossman
Colin P Dinney
Núria Malats
Xifeng Wu
National School of Public Health · GRCenter for Research in Environmental Epidemiology · ESMunicipal Institute for Medical Research · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDivision of Cancer Epidemiology and GeneticsSpanish National Cancer Research Centre · ESCentro de Investigación del Cáncer · ESNational Cancer Institute · USThe University of Texas MD Anderson Cancer Center · US

Funding

Targeting Ral GTPases in Bladder CancerP50CA091846 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., MCCONKEY, DAVID J. · 2001 to 2018
$37.4M
Genome-Wide Association Analysis of Bladder CancerU01CA127615 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 2008 to 2012
$5.1M
Markers of Genetic Susceptibility to Bladder CancerR01CA074880 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 1999 to 2008
$3.1M
Genetic Instability & Risk for Esophageal CarcinomaR01CA111922 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 2008 to 2012
$2.9M
Telomere length, telomere maintenance gene polymorphisms, and bladder cancer riskR01CA131335 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GU, JIAN · 2008 to 2011
$1.3M
NCI NIH HHS P50 CA091846NCI NIH HHS P50 CA 91846NCI NIH HHS R01 CA074880NCI NIH HHS R01 CA111922NCI NIH HHS R01 CA 131335NCI NIH HHS R01 CA131335NCI NIH HHS R01 CA 74880NCI NIH HHS U01 CA 127615NCI NIH HHS U01 CA127615
6 · The paper itself

Abstract

Sonic hedgehog (Shh) pathway genetic variations may affect bladder cancer risk and clinical outcomes. Therefore, we genotyped 177 single-nucleotide polymorphisms (SNP) in 11 Shh pathway genes in a study including 803 bladder cancer cases and 803 controls. We assessed SNP associations with cancer risk and clinical outcomes in 419 cases of non-muscle-invasive bladder cancer (NMIBC) and 318 cases of muscle-invasive and metastatic bladder cancer (MiMBC). Only three SNPs (GLI3 rs3823720, rs3735361, and rs10951671) reached nominal significance in association with risk (P ≤ 0.05), which became nonsignificant after adjusting for multiple comparisons. Nine SNPs reached a nominally significant individual association with recurrence of NMIBC in patients who received transurethral resection (TUR) only (P ≤ 0.05), of which two (SHH rs1233560 and GLI2 rs11685068) were replicated independently in 356 TUR-only NMIBC patients, with P values of 1.0 × 10(-3) (SHH rs1233560) and 1.3 × 10(-3) (GLI2 rs11685068). Nine SNPs also reached a nominally significant individual association with clinical outcome of NMIBC patients who received Bacillus Calmette-Guérin (BCG; P ≤ 0.05), of which two, the independent GLI3 variants rs6463089 and rs3801192, remained significant after adjusting for multiple comparisons (P = 2 × 10(-4) and 9 × 10(-4), respectively). The wild-type genotype of either of these SNPs was associated with a lower recurrence rate and longer recurrence-free survival (versus the variants). Although three SNPs (GLI2 rs735557, GLI2 rs4848632, and SHH rs208684) showed nominal significance in association with overall survival in MiMBC patients (P ≤ 0.05), none remained significant after multiple-comparison adjustments. Germ-line genetic variations in the Shh pathway predicted clinical outcomes of TUR and BCG for NMIBC patients.

Indexed as

Genetic Predisposition to DiseaseAgedAntineoplastic AgentsBCG VaccineCarcinoma, Transitional CellCase-Control StudiesDrug Resistance, NeoplasmFemaleGenotypeHedgehog ProteinsHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingAntineoplastic AgentsBCG VaccineHedgehog Proteins

Identifiers

PMID20858759
PMCPMC2955764
OpenAlexW2137471416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.